{"transactions":[{"id":2172013,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"(Former) Chief Scientific Off."}}],"security":"Stock option (right to buy)","published_at":"2022-08-29T16:45:35.000Z","date":"2022-08-22","kind":"exercise","acquired":false,"shares":2640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period."}],"balance_after":58085,"derivative":{"exercise_price":0.57,"exercise_date":"2021-06-05","expiration_date":"2031-03-01","underlying":"Class A common stock","underlying_shares":2640},"source":{"system":"sec-edgar","filing":"0001437749-22-021457","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922021457/rdgdoc.xml","form_type":"4"}},{"id":2172012,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"(Former) Chief Scientific Off."}}],"security":"Stock option (right to buy)","published_at":"2022-08-29T16:45:35.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":26005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period."}],"balance_after":60725,"derivative":{"exercise_price":0.57,"exercise_date":"2021-06-05","expiration_date":"2031-03-01","underlying":"Class A common stock","underlying_shares":26005},"source":{"system":"sec-edgar","filing":"0001437749-22-021457","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922021457/rdgdoc.xml","form_type":"4"}},{"id":2172011,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"(Former) Chief Scientific Off."}}],"security":"Stock option (right to buy)","published_at":"2022-08-29T16:45:35.000Z","date":"2022-07-29","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person's Form 4 filed on May 5, 2022 incorrectly reported that the Reporting Person owned 116,730 of these stock options after the transaction on May 3, 2022 but the Reporting Person then owned 106,730 of these stock options."}],"balance_after":86730,"derivative":{"exercise_price":0.57,"exercise_date":"2021-06-05","expiration_date":"2031-03-01","underlying":"Class A common stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-22-021457","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922021457/rdgdoc.xml","form_type":"4"}},{"id":2172010,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"(Former) Chief Scientific Off."}}],"security":"Stock option (right to buy)","published_at":"2022-08-29T16:45:35.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period."}],"balance_after":116730,"derivative":{"exercise_price":0.57,"exercise_date":"2021-06-05","expiration_date":"2031-03-01","underlying":"Class A common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-22-021457","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922021457/rdgdoc.xml","form_type":"4"}},{"id":2172009,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"(Former) Chief Scientific Off."}}],"security":"Class A common stock","published_at":"2022-08-29T16:45:35.000Z","date":"2022-08-22","kind":"exercise","acquired":true,"shares":2640,"price":0.57,"value":1504.8,"ownership":{"direct":true},"balance_after":68645,"source":{"system":"sec-edgar","filing":"0001437749-22-021457","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922021457/rdgdoc.xml","form_type":"4"}},{"id":2172008,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"(Former) Chief Scientific Off."}}],"security":"Class A common stock","published_at":"2022-08-29T16:45:35.000Z","date":"2022-08-15","kind":"exercise","acquired":true,"shares":26005,"price":0.57,"value":14822.85,"ownership":{"direct":true},"balance_after":66005,"source":{"system":"sec-edgar","filing":"0001437749-22-021457","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922021457/rdgdoc.xml","form_type":"4"}},{"id":2172007,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"(Former) Chief Scientific Off."}}],"security":"Class A common stock","published_at":"2022-08-29T16:45:35.000Z","date":"2022-07-29","kind":"exercise","acquired":true,"shares":20000,"price":0.57,"value":11400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person's Form 4 filed on May 5, 2022 incorrectly reported that the Reporting Person owned 10,000 shares of Class A common stock after the transaction on May 3, 2022 but the Reporting Person then owned 20,000 shares of Class A common stock."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001437749-22-021457","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922021457/rdgdoc.xml","form_type":"4"}},{"id":2172006,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"(Former) Chief Scientific Off."}}],"security":"Class A common stock","published_at":"2022-08-29T16:45:35.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":10000,"price":0.57,"value":5700.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-22-021457","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922021457/rdgdoc.xml","form_type":"4"}},{"id":2280954,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-05T13:39:35.000Z","date":"2022-05-03","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period."}],"balance_after":116730,"derivative":{"exercise_price":0.57,"expiration_date":"2031-03-01","underlying":"Class A common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-016779","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924322016779/doc4.xml","form_type":"4"}},{"id":2280953,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A common stock","published_at":"2022-05-05T13:39:35.000Z","date":"2022-05-03","kind":"exercise","acquired":true,"shares":10000,"price":0.57,"value":5700.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-22-016779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924322016779/doc4.xml","form_type":"4"}},{"id":2513056,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-11-15T18:50:54.000Z","date":"2021-11-11","kind":"grant","acquired":true,"shares":41958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are subject to a four-year time-vesting schedule, with 25% vesting on the first anniversary of the grant date] and the remainder vesting in equal installments each month during the remainder of the vesting period."}],"balance_after":41958,"derivative":{"exercise_price":13,"expiration_date":"2031-11-11","underlying":"Class A common stock","underlying_shares":41958},"source":{"system":"sec-edgar","filing":"0000899243-21-044646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924321044646/doc4.xml","form_type":"4"}},{"id":3725671,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:31:55.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":625000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001437749-18-022291","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022291/rdgdoc.xml","form_type":"4"}},{"id":4123003,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Purchase Option","published_at":"2017-12-22T16:24:37.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":500000,"derivative":{"exercise_price":0.05,"expiration_date":"2027-12-20","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001437749-17-021096","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774917021096/rdgdoc.xml","form_type":"4"}},{"id":4521227,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"Sr VP, Research & Development"}}],"security":"Common Stock Purchase Option","published_at":"2016-12-15T21:28:10.000Z","date":"2016-12-13","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":85000,"derivative":{"exercise_price":0.0652,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001437749-16-043424","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774916043424/rdgdoc.xml","form_type":"4"}},{"id":4521228,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"Sr VP, Research & Development"}}],"security":"Common Stock Purchase Option","published_at":"2016-12-15T21:27:50.000Z","date":"2016-12-13","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":85000,"derivative":{"exercise_price":0.0652,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001437749-16-043423","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774916043423/rdgdoc.xml","form_type":"4"}}]}